NCT00420836View on ClinicalTrials.gov

Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2006

Conditions
Cystic Fibrosis
Interventions
DRUG

Tobramycin

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00420836 - Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study | Biotech Hunter | Biotech Hunter